Suchergebnisse - "Dalal, Rahul S"

PubPharm (5)

1

Activity of axial spondyloarthritis after one year of anti-tumor necrosis factor therapy among patients with inflammatory bowel diseases

enthalten in: Clinical rheumatology | 2023

von Dalal, R. | Ermann, J. | Carlin, A. | +2

2

Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease : A Danish Nationwide Cohort Study

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Lund, K. | Zegers, F. | +3

3

Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Pruce, J. | Allegretti, J.

4

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Gupta, S. | Goodrick, H. | +2

5

Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Njie, C. | Marcus, J. | +2

CommentIn: Inflamm Bowel Dis. 2021 May 17;27(6):e69. - PMID 33570129

1
[1]